We report a patient with chronic bronchiectasis who developed systemic vasculitis. The patient was initially treated with immunosuppression; however, the addition of antibiotic therapy improved control of her vasculitis and the need for immunosuppression was reduced. Chronic bronchial suppuration may have an aetiological role in the pathogenesis of this condition.
Introduction
Vasculitis associated with chronic suppurative lung disease has been reported in a few cases of bronchiectasis and cystic fibrosis.'-7 We report the case of a 47-year-old female with chronic bronchiectasis who presented with cutaneous and mesenteric vasculitis requiring smallbowel resection, whose vasculitis appeared to improve with control of her chest condition. We also review the literature regarding the association between these conditions and consider the differential diagnosis, pathogenesis and management of vasculitis in this situation.
Case report
The patient, a 47-year-old female developed bronchiectasis following an episode of whooping cough at 10 years old. In March 1991 she presented with a one-month history of a migratory papular, non-itchy skin rash over the dorsa of both hands, her forearms and thighs, diagnosed as chronic urticaria. Two months later she complained of intermittent joint pain and swelling. A diagnosis of palindromic rheumatism was made and treatment with ibuprofen achieved no improvement. These symptoms persisted over the next few months and in October 1991 she was admitted with a fourweek history of crampy abdominal pain, diarrhoea and a 7-kg weight loss. A small bowel series suggested a diagnosis of Crohn's disease affecting her terminal ileum and she was started on 5-aminosalicylic acid 2 g and prednisolone 30 mg daily with symptomatic improvement.
Two weeks following discharge she was readmitted with a perforation of her proximal jejunum diagnosed at emergency laparotomy. On inspection, the vessels to this area were thrombosed and no nodules were visible; the remaining bowel, including the distal ileum, appeared normal. She underwent resection of 20 cm of jejunum and had an uneventful postoperative recovery. Histological examination of the specimen adjacent to the perforation showed extensive mucosal ulceration with numerous fissure ulcers extending into the submucosa, no granulomata were seen. Arterioles within the bowel wall and adjacent mesentery showed arteritis with inflammation ofthe wall, recent and recanalizing thrombi and focal disruption of the internal elastic lamina (figures 1 and 2).
Other investigations during this admission showed a normal urinalysis, serum creatinine and white cell count, while her eosinophil count was 1%. Complement factors C3 and C4 were 0.54g/l (0.75-1.5) and 0.09 g/l (0.09-0.34), respectively. 13 .5 g/l (7) (8) (9) (10) (11) (12) (13) (14) , IgA 4.39 g/l (0.8-4.0), IgM 0.82 g/l (0.45-2.0), and pANCA 1/80; anti-MPO was not detected. CT scan of the chest showed diffuse multilobular bronchiectatic changes in both lung fields. She was initially commenced on a seven-day course of intravenous ceftazidime followed by continuous oral co-trimoxazole 400 mg daily.
Since commencement of antibiotics she has experienced a dramatic improvement in the frequency of her rash with no new lesions having developed in the past nine months; she has had no further abdominal or joint symptoms. Her daily sputum volume has also reduced. In view of this improvement, her immunosuppression has been reduced to cyclophosphamide 50 mg daily monotherapy. In this period her antibiotic has been changed approximately every three months and she is currently on doxycycline 100 mg/day, with continued control of her condition.
Discussion
The association of vasculitis with chronic suppurative lung disease has been reported both in patients with cystic fibrosis and acquired bronchiectasis.''7 Our patient had a definite history ofonset ofher bronchiectasis after an episode of whooping cough when aged 10 years old. She ha-s not had a sweat test but the absence of typical features expected in cystic fibrosis on her small bowel histology accords with acquired bronchiectasis. 9 When such patients develop vasculitis, several differential diagnoses need to be considered namely, drug-induced vasculitis,'0 cryoglobulinaemia," and hypergammaglobulinaemic purpura,12 the Finnegan et al4 noted that 40QO of patients with cystic fibrosis and vasculitis had antineutrophil cytoplasmic antibodies (ANCA) present. Including our case, seven out of 14 cases in which ANCA was tested were [2] [3] [4] positive. -Five were cytoplasmic pattern (c-ANCA)2'4 and one was perinuclear staining (p-ANCA).2 Our patient was p-ANCA positive but anti-MPO negative, indicating an alternative antigenic specificity.2" ANCA in this setting may simply be a phenomenon secondary to chronic neutrophil destruction2 since others have noted ANCA in patients with cystic fibrosis without evidence of vasculitis.24 It has, however, been suggested that ANCA may be pathogenic in vasculitis, either by recognition of endothelial-bound ANCA autoantigens,2'5 or by enhancing oxyradical production from neutrophils, the latter occurring after the cells have been 'primed' by cytokines, eg, TNF-x. 26 The cytokines present in patients with an exacerbation of bronchiectasis, together with circulating ANCA may therefore represent an in vivo model of the pathogenesis of ANCArelated vasculitis proposed by Falk and Jennette26 and hence the apparent coincidental finding of ANCA in uncomplicated cystic fibrosis may put such patients 'at risk' of vasculitic complications. Finally, vasculitis commonly occurs at areas of turbulent flow or increased hydrostatic pressure, factors which facilitate immune complex deposition.27 In Hilton's series two patients had cor pulmonale, with improvement of the vasculitis in one following treatment for this alone.' The increased venous pressure induced by this complication may explain this and also the late onset of vasculitis in most cases.
Management of this condition reflects its variable extent and course, in some cases the cutaneous vasculitis has resolved spontaneously, in others systemic vasculitis has run a fulminating and rapidly fatal course. Twelve cases reviewed had disease of sufficient severity to indicate immunosuppressive therapy, only one of whom did not improve.4 Immunosuppression can also improve chest symptoms when they are presumably caused by immune complexes or inflammatory mediators.32' Hilton et al described one case with recurrent cutaneous vasculitis which improved on prophylactic antibiotics.' In parallel with the clinical improvement, the levels of circulating immune complexes were also reduced. Fradin et al noted a similar dramatic response to intravenous antibiotic therapy in their patient with cutaneous vasculitis.7 Our case also had a dramatic improvement in her rash following intensive anitbiotic therapy which has now been maintained for more than nine months on prophylactic antibiotics. The improvement is related to antibiotic chemotherapy and not to the proposed beneficial effect of co-trimoxazole on vasculitis,28 as it is sustained on alternative regimes. If this condition can be significantly improved by control of the chest sepsis it may be postulated that a 'cure' could be achieved by surgical resection of the affected segment of lung. As with our patient, most will have diffuse involvement, ruling out such intervention, nevertheless this option may be available to a few selected patients. Other measures to optimise concurrent problems, eg, cor pulmonale, also seems to be of benefit in some patients.'
Therefore, in patients with vasculitis associated with chronic suppurative lung disease, the differential diagnosis described above should be considered and systemic involvement should be carefully sought. In cases with systemic vasculitis, immunosuppression with steroids and cyclophosphamide will control disease without any detrimental effects on lung function. Treatment with appropriate antibiotics has a useful role in some cases, presumably by reducing the antigenic load and, as a result, the volume of immune complexes produced. This case further demonstrates that antibiotic prophylaxis may help control the vasculitis and also reduce the need for systemic immunosuppression. 
